Last $0.37 USD
Change Today -0.0001 / -0.03%
Volume 151.6K
GENE On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
Frankfurt
As of 8:10 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - genetic tech ltd-sp adr (GENE)

Name (Connections)Board RelationshipsTitleKey Developments
Grahame Leonard AM, BA (Hons), LLB, CA, CPA, FAICD (Dip), AFAIM, O 4 RelationshipsNon-Executive Director and Chairman of Audit Committee 
Paul Kasian AM, Ph.D., MBA 4 RelationshipsNon-Executive Director and Member of Audit Committee 

Corporate Governance Committee* - genetic tech ltd-sp adr (GENE)

Name (Connections)Board RelationshipsTitle
Malcolm Brandon BScAgr, Ph.D., MAICD 4 Relationships--
GENE and Competitor
Insiders vs. External
Board
0%
100%
Genetic Technologies Limited
11%
89%
Agilent Technologies Inc.
45%
55%
Sonic Healthcare Limited
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GENE:US $0.37 USD -0.0001

GENE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Agilent Technologies Inc $41.88 USD +0.50
Sonic Healthcare Ltd A$18.51 AUD +0.27
View Industry Companies
 

Industry Analysis

GENE

Industry Average

Valuation GENE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETIC TECH LTD-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.